Boston Outstanding Business Development

Strategy:

• Identified and connected with target client via LinkedIn and other channels
• Established preliminary trust through virtual meetings, followed by executive-level onsite visit to client HQ at optimal timing
• Secured first project rapidly, opening collaboration pipeline

Trust-Building & Project Expansion:

• Provided rapid response during first project delivery, conducting multiple virtual/onsite meetings to clarify requirements
• Arranged lab tours and facilitated quality system audits
• Received exceptional service evaluation and outstanding project results, leading to swift initiation of multiple cross-departmental follow-up projects

Outcomes:

• Transitioned client from initial contact to comprehensive collaboration
• Cumulative project value reached ~$2 million USD
• Established long-term trusted partnership with ongoing internal referrals

Objectives:

Support client's first formal GLP/non-GLP audits in China, build long-term trust, and advance early-stage evaluation/planning for local NHP projects (potential value >$10M).

Execution:

Initial Contact:

Established connection with client executives at an international biopharma conference (Nov 2022). Despite initial disinterest, maintained regular communication to gradually facilitate executive-level dialogue.

Strategic Opportunity:

Capitalized on Cambodia wild monkey trade disruption (Feb 2024) which severely impacted NHP imports (e.g., Charles River project suspension), prompting client to urgently reevaluate global supply chains and consider China-based alternatives.

Implementation:

Coordinated compliant CRO audits and submitted competitive NHP project proposals/timelines to strengthen trust.

Results:

• Successfully completed client's first China GLP/non-GLP audits
• Potential project value exceeding $10 million
• Significantly enhanced client confidence in China's preclinical platforms, laying foundation for strategic long-term collaboration

Services:

• Analyzed client strategy and recommended antibody discovery as entry point
• Custom-matched macromolecule platform partners and facilitated collaboration setup
• Advised on service scope, pricing, and timelines to reach agreement

Outcomes:

• Initiated first antibody discovery project within 3 months of engagement
• Positive client feedback leading to planned ADC conjugation/optimization services
• Partner acknowledged client's professionalism and long-term potential

Project Timeline:

Completed entire process from strategic consultation to project launch in 3.5 months